Amedisys Inc.
AMED
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.32B
Close$
$112.84
11.7% upside
Current Fair Value
11.7% upsideUndervalued by 11.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.32 Billion |
|---|---|
| Enterprise Value | $3.30 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.32 |
| Beta | 0.9 |
| Outstanding Shares | 32,849,000 |
Return
| Return on Equity | 12.75% |
|---|---|
| Return on Assets | 7.09% |
| Return on Invested Capital | 7.05% |
Valuation & Multiples
| P/E Ratio | 25.76 |
|---|---|
| PEG | 23.57 |
| Price to Sales | 1.38 |
| Price to Book Ratio | 2.66 |
| Enterprise Value to Revenue | 1.37 |
| Enterprise Value to EBIT | 27.09 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.25 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 31.7054▲ 774.00% |
|---|---|
| Total Calls | 78,400▲ 8.59% |
| Total Puts | 2,485,700▲ 43.66% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 100.46%▲ 3.68% |
|---|---|
| Total Invested | $3.25B▲ 10.42% |
| Investors Holding | 344▲ 18.00% |
ESG Score
No data
About Amedisys Inc.
CEO: Paul Kusserow